Pulished Date August, 2019
ID: 205
Share on
Share on

Plasma Protein Therapeutics Market Analysis - By Product Type (Immunoglobulins, Albumin, Coagulation Factors, Alpha-1 Proteinase Inhibitor, Others) By Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency And Others), By Region - Global Industry Analysis, Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 205
Pages: 171

Plasma Protein Therapeutics Market Size & Growth (2019 - 2024)

As per the report, the size of the Global Plasma Protein Therapeutics Market is estimated to be at USD 23935.47 Million in 2019 and is poised to reach USD 36777.04 Million by 2024 with a CAGR of 8.97%.

Plasma is a protein-rich fluid and plays a crucial role in clotting and providing immunity to diseases. By isolating the proteins from plasma, they can be used for medical therapies including autoimmune, immune deficiencies, neurological and bleeding disorders. Plasma protein therapies are used to treat the well-defined medical conditions by replacing the deficient or missing proteins in plasma. Plasma protein therapeutics involves biological medicines either infused or injected to treat life-threatening, chronic and genetic diseases.

The use of plasma protein in medical applications has increased significantly in recent years. With the advancements in technology, the process for fractionating the protein from plasma has become more cost-saving and efficient and is supposed to boost the plasma protein therapeutics market. According to WHO reports more than half of the global blood donors belong to high-income countries which constitute 18% of the population. With rising awareness among people regarding blood donations and government initiatives, the plasma-derived medicine market is expected to grow at a significant rate in the coming years.

Increasing the introduction of new plasma-derived therapies is the primary driving factor for the market. The market is also driven by a host of other factors, including the rising prevalence of life-threatening diseases involving immune or neurological systems and other infectious diseases like Rabies, Tetanus, Hepatitis A&B and varicella.

On the contrary, there are a few restraints for the market which include stringent government policies, issues pertaining to reimbursement, complexity in manufacturing.

Growth opportunities for the market lie in the increasing use of these plasma proteins in pharmaceutical which are effectively used for the treatment of various diseases like hemostasis. Growing awareness on the utilization of various components in the laboratories which are highly effective and promote a modernized way of treatment procedures is greatly influencing the demand of the market. Also, the plasma protein therapeutics market is driven by rising incidences of genetic disorder diseases across the world. The trend towards detecting the diseases at an early stage by diagnosing as early as possible is enhancing the growth rate of the market. From the past two decades, the demand for targeted therapies is growing tremendously which is solely to level up the growth rate of the market. Also, these therapies offer custom made treatment procedures for the patients which are specifically to meet the desired outcomes. The aforementioned factor is additionally fueling the demand of the market to the extent. 

Major players leading the Global Plasma Protein Therapeutics Market in this report are:

  1. Baxter
  2. CSL Behring
  3. Biotest
  4. China Biologics
  5. Grifols
  6. Kedrion
  7. Octapharma
  8. Shire Plc.
  9. Chengdu Inst

Recent Market Developments:

June 2016 - Acquisition

Baxalta was acquired by Shire Plc which enhanced the shares of the company and also developed its product portfolio. The main aim to create a strong pipeline for the treatment of varied diseases which occur rarely. 

August 2018 - Acquisition

In U.S. Grifols S.A. acquired 24 plasma donor centers which have thrived the position of the company and Biotest AG will operate these companies to improve shares. 

March 2018 - Product Approval

The first immunoglobulin therapy got approval from food and drug administration (FDA) is developed by CSL’s Hizentra and this is highly used in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP). 

This report on the Global Plasma Protein Therapeutics Market has been segmented & sub-segmented into the following categories and analyzed market size & forecast for each segment until 2024.

Plasma Protein Therapeutics Market – By Type

  • Albumin
  • Coagulation Factors
  • Alpha-1 proteinase inhibitor
  • Others

Based on the type, the market is held by the Albumin segment with the rising prevalence of quality treatment procedures. Besides, growing focus on implementing various therapies for infectious diseases and to lower the complexity in real-time applications are escalating the demand of the market.

Plasma Protein Therapeutics Market – By Application

  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Idiopathic Thrombocytopenic Purpura
  • Secondary Immunodeficiency
  • Others

On the basis of application, Hemophilia is accounted for in holding the highest shares of the market. Increasing geriatric population and a growing number of patients with life-threatening diseases are primary factors for the market to grow enormously. Rising investments in the construction of hospitals by both private and public sectors are prompting the demand of the market. Also, changes in the food habits and adoption of sedentary lifestyles especially in urban areas is lavishing the growth of the plasma protein therapeutics market. 

Plasma Protein Therapeutics Market – By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle-East & Africa

Regionally, North America is positioned at the top in holding dominant shares of the market. Increasing capital income in both developed and developing countries is the primary factor for the market to grow. The emergence of modern technologies and the launch of innovative therapies are eventually focusing on boosting up the demand of this market. Europe is following North America is leading the highest shares of the market with the rising support from government bodies in changing schemes and implementation of reimbursement in favor of the end-users. The Asia Pacific is witnessed in having the fastest growth rate from the past decade and is also to continue the same flow in foreseen years. India and China are major countries contributing to the highest shares for market growth. Increasing chronic and infectious diseases along with the growing geriatric population is certainly a major factor for the market to grow in this region. 

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. Product
      1. Introduction
      2. Albumin
      3. Coagulation Factors
      4. Alpha-1 proteinase inhibitor
      5. Others
    2. Application
      1. Introduction
      2. Hemophilia
      3. Primary Immunodeficiency Disorder
      4. Idiopathic Thrombocytopenic Purpura
      5. Secondary Immunodeficiency
      6. Others
  6. Geographical Analysis
    1. North America
      1. Introduction
      2. United States
      3. Canada
    2. Europe
      1. Introduction
      2. U K
      3. Spain
      4. Germany
      5. Italy
      6. France
    3. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
    4. Latin America
      1. Introduction
      2. Brazil
      3. Rest of Latin America
    5. Middle East & Africa
      1. Introduction
      2. Middle-East
      3. South Africa
      4. Rest of Middle East & Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Baxter
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Biotest
    3. China Biologics
    4. Grifols
    5. Kedrion
    6. Octapharma
    7. Shire Plc.
    8. Chengdu Inst
    9. Competitive Landscape
    10. Market share analysis
    11. Merger and Acquisition Analysis
    12. Agreements, collaborations and Joint Ventures
    13. New Product Launches
  9. Expert Opinions
    1. Market Outlook
    2. Investment Opportunities
  10. Appendix
    1. List of Tables
    2. List of Figures
  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  • Global Plasma Protein Therapeutics Market By Type, From 2019 - 2024 (USD Million)
  • Global Plasma Protein Therapeutics Market By Application, From 2019 - 2024 (USD Million)
  • Global Immunoglobulins Market By Region, From 2019 - 2024 (USD Million)
  • Global Albumin Market By Region, From 2019 - 2024 (USD Million)
  • Global Coagulation Factors Market By Region, From 2019 - 2024 (USD Million)
  • Global Alpha-1 proteinase inhibitor Market By Region, From 2019 - 2024 (USD Million)
  • Global Others Market By Region, From 2019 - 2024 (USD Million)
  • Global Hemophilia Market By Region, From 2019 - 2024 (USD Million)
  • Global Primary Immunodeficiency Disorder Market By Region, From 2019 - 2024 (USD Million)
  • Global Idiopathic Thrombocytopenic Purpura Market By Region, From 2019 - 2024 (USD Million) 
  • Global Secondary Immunodeficiency Market By Region, From 2019 - 2024 (USD Million) 
  • Global Others Market By Region, From 2019 - 2024 (USD Million)
  • North America Plasma Protein Therapeutics Market By Type, From 2019 - 2024 (USD Million)
  • North America Plasma Protein Therapeutics Market By Application, From 2019 - 2024 (USD Million)
  • North America Immunoglobulins Market By Region, From 2019 - 2024 (USD Million)
  • North America Albumin Market By Region, From 2019 - 2024 (USD Million)
  • North America Coagulation Factors Market By Region, From 2019 - 2024 (USD Million)
  • North America Alpha-1 proteinase inhibitor Market By Region, From 2019 - 2024 (USD Million)    
  • North America Others Market By Region, From 2019 - 2024 (USD Million)
  • North America Hemophilia Market By Region, From 2019 - 2024 (USD Million)
  • North America Primary Immunodeficiency Disorder Market By Region, From 2019 - 2024 (USD Million)    
  • North America Idiopathic Thrombocytopenic Purpura Market By Region, From 2019 - 2024 (USD Million)
  • North America Secondary Immunodeficiency Market By Region, From 2019 - 2024 (USD Million) 
  • North America Others Market By Region, From 2019 - 2024 (USD Million)
  • Europe Plasma Protein Therapeutics Market By Type, From 2019 - 2024 (USD Million)
  • Europe Plasma Protein Therapeutics Market By Application, From 2019 - 2024 (USD Million)
  • Europe Immunoglobulins Market By Region, From 2019 - 2024 (USD Million)
  • Europe Albumin Market By Region, From 2019 - 2024 (USD Million)
  • Europe Coagulation Factors Market By Region, From 2019 - 2024 (USD Million)    
  • Europe Alpha-1 proteinase inhibitor Market By Region, From 2019 - 2024 (USD Million)   
  • Europe Others Market By Region, From 2019 - 2024 (USD Million)
  • Europe Hemophilia Market By Region, From 2019 - 2024 (USD Million)
  • Europe Primary Immunodeficiency Disorder Market By Region, From 2019 - 2024 (USD Million)   
  • Europe Idiopathic Thrombocytopenic Purpura Market By Region, From 2019 - 2024 (USD Million)
  • Europe Secondary Immunodeficiency Market By Region, From 2019 - 2024 (USD Million)
  • Europe Others Market By Region, From 2019 - 2024 (USD Million)
  • Asia-Pacific Plasma Protein Therapeutics Market By Type, From 2019 - 2024 (USD Million)
  • Asia-Pacific Plasma Protein Therapeutics Market By Application, From 2019 - 2024 (USD Million)  
  • Asia-Pacific Immunoglobulins Market By Region, From 2019 - 2024 (USD Million) 
  • Asia-Pacific Albumin Market By Region, From 2019 - 2024 (USD Million)   
  • Asia-Pacific Coagulation Factors Market By Region, From 2019 - 2024 (USD Million)
  • Asia-Pacific Alpha-1 proteinase inhibitor Market By Region, From 2019 - 2024 (USD Million)
  • Asia-Pacific Others Market By Region, From 2019 - 2024 (USD Million)
  • Asia-Pacific Hemophilia Market By Region, From 2019 - 2024 (USD Million)
  • Asia-Pacific Primary Immunodeficiency Disorder Market By Region, From 2019 - 2024 (USD Million)
  • Asia-Pacific Idiopathic Thrombocytopenic Purpura Market By Region, From 2019 - 2024 (USD Million)
  • Asia-Pacific Secondary Immunodeficiency Market By Region, From 2019 - 2024 (USD Million)
  • Asia-Pacific Others Market By Region, From 2019 - 2024 (USD Million)
  • Latin America Plasma Protein Therapeutics Market By Type, From 2019 - 2024 (USD Million)
  • Latin America Plasma Protein Therapeutics Market By Application, From 2019 - 2024 (USD Million)
  • Latin America Immunoglobulins Market By Region, From 2019 - 2024 (USD Million)
  • Latin America Albumin Market By Region, From 2019 - 2024 (USD Million)
  • Latin America Coagulation Factors Market By Region, From 2019 - 2024 (USD Million)
  • Latin America Alpha-1 proteinase inhibitor Market By Region, From 2019 - 2024 (USD Million)
  • Latin America Others Market By Region, From 2019 - 2024 (USD Million) 
  • Latin America Hemophilia Market By Region, From 2019 - 2024 (USD Million)
  • Latin America Primary Immunodeficiency Disorder Market By Region, From 2019 - 2024 (USD Million)
  • Latin America Idiopathic Thrombocytopenic Purpura Market By Region, From 2019 - 2024 (USD Million)   
  • Latin America Secondary Immunodeficiency Market By Region, From 2019 - 2024 (USD Million)   
  • Latin America Others Market By Region, From 2019 - 2024 (USD Million) 
  • Middle East & Africa Plasma Protein Therapeutics Market By Type, From 2019 - 2024 (USD Million)
  • Middle East & Africa Plasma Protein Therapeutics Market By Application, From 2019 - 2024 (USD Million)
  • Middle East & Africa Immunoglobulins Market By Region, From 2019 - 2024 (USD Million)
  • Middle East & Africa Albumin Market By Region, From 2019 - 2024 (USD Million) 
  • Middle East & Africa Coagulation Factors Market By Region, From 2019 - 2024 (USD Million)
  • Middle East & Africa Alpha-1 proteinase inhibitor Market By Region, From 2019 - 2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample